205 related articles for article (PubMed ID: 25923701)
1. STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells.
Ma Y; Zhang X; Xu X; Shen L; Yao Y; Yang Z; Liu P
PLoS One; 2015; 10(4):e0124924. PubMed ID: 25923701
[TBL] [Abstract][Full Text] [Related]
2. Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo.
Zhang X; Lu T; Ma Y; Li R; Pang Y; Mao H; Liu P
Onco Targets Ther; 2020; 13():5069-5082. PubMed ID: 32606729
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
4. Blockage of STAT3 signaling pathway with a decoy oligodeoxynucleotide inhibits growth of human ovarian cancer cells.
Liu M; Wang F; Wen Z; Shi M; Zhang H
Cancer Invest; 2014 Jan; 32(1):8-12. PubMed ID: 24328557
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
6. Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells.
Zhang X; Liu P; Zhang B; Wang A; Yang M
Cancer Genet Cytogenet; 2010 Feb; 197(1):46-53. PubMed ID: 20113836
[TBL] [Abstract][Full Text] [Related]
7. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
8. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes.
Zhang X; Zhang J; Wei H; Tian Z
Oncol Rep; 2007 Jun; 17(6):1377-82. PubMed ID: 17487394
[TBL] [Abstract][Full Text] [Related]
9. A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.
Souissi I; Najjar I; Ah-Koon L; Schischmanoff PO; Lesage D; Le Coquil S; Roger C; Dusanter-Fourt I; Varin-Blank N; Cao A; Metelev V; Baran-Marszak F; Fagard R
BMC Cell Biol; 2011 Apr; 12():14. PubMed ID: 21486470
[TBL] [Abstract][Full Text] [Related]
10. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.
Gu J; Li G; Sun T; Su Y; Zhang X; Shen J; Tian Z; Zhang J
J Neurooncol; 2008 Aug; 89(1):9-17. PubMed ID: 18415045
[TBL] [Abstract][Full Text] [Related]
11. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
Shen J; Li R; Li G
In Vivo; 2009; 23(2):237-43. PubMed ID: 19414409
[TBL] [Abstract][Full Text] [Related]
13. Inorganic Kernel-Reconstituted Lipoprotein Biomimetic Nanovehicles Enable Efficient Targeting "Trojan Horse" Delivery of STAT3-Decoy Oligonucleotide for Overcoming TRAIL Resistance.
Shi K; Xue J; Fang Y; Bi H; Gao S; Yang D; Lu A; Li Y; Chen Y; Ke L
Theranostics; 2017; 7(18):4480-4497. PubMed ID: 29158840
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor Growth.
Kopechek JA; Carson AR; McTiernan CF; Chen X; Hasjim B; Lavery L; Sen M; Grandis JR; Villanueva FS
Theranostics; 2015; 5(12):1378-87. PubMed ID: 26681983
[TBL] [Abstract][Full Text] [Related]
15. (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway.
Cho SH; Park MH; Lee HP; Back MK; Sung HC; Chang HW; Kim JH; Jeong HS; Han SB; Hong JT
Arch Pharm Res; 2014 May; 37(5):652-61. PubMed ID: 24390815
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells.
Jiang L; Luo RY; Yang J; Cheng YX
Mol Med Rep; 2013 Feb; 7(2):425-30. PubMed ID: 23229441
[TBL] [Abstract][Full Text] [Related]
17. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
[TBL] [Abstract][Full Text] [Related]
18. STAT3-decoy ODN inhibits cytokine autocrine of murine tumor cells.
Liu X; Li J; Zhang J
Cell Mol Immunol; 2007 Aug; 4(4):309-13. PubMed ID: 17764622
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.
Sun X; Zhang J; Wang L; Tian Z
Cancer Lett; 2008 Apr; 262(2):201-13. PubMed ID: 18248786
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human ovarian cancer cells by blocking STAT3 activation with small interfering RNA.
Cai L; Zhang G; Tong X; You Q; An Y; Wang Y; Guo L; Wang T; Zhu D; Zheng J
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):73-80. PubMed ID: 19880237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
